We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
-$5M
Cap. Flow %
-0.12%
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.3M
2
AMZN icon
Amazon
AMZN
+$27.7M
3
PLTR icon
Palantir
PLTR
+$17.5M
4
HIMS icon
Hims & Hers Health
HIMS
+$13.7M
5
YUMC icon
Yum China
YUMC
+$13.2M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$39.4M
2
NVDA icon
NVIDIA
NVDA
+$30.1M
3
META icon
Meta Platforms (Facebook)
META
+$14.9M
4
BEKE icon
KE Holdings
BEKE
+$14.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 42.45%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PECO icon
376
Phillips Edison & Co
PECO
$5.46B
$84.7K ﹤0.01%
2,322
+96
+4% +$3.47K
SWTX
377
DELISTED
SpringWorks Therapeutics
SWTX
$84.1K ﹤0.01%
1,905
+343
+22% +$15.8K
RYTM icon
378
Rhythm Pharmaceuticals
RYTM
$6.81B
$83.3K ﹤0.01%
1,573
+283
+22% +$15.7K
MAC icon
379
Macerich
MAC
$7.33B
$80.8K ﹤0.01%
4,707
+191
+4% +$3.65K
CRNX icon
380
Crinetics Pharmaceuticals
CRNX
$8.84B
$79.7K ﹤0.01%
2,375
+428
+22% +$16K
SLG icon
381
SL Green Realty
SLG
$3.76B
$78.4K ﹤0.01%
1,359
+181
+15% +$11.4K
SBRA icon
382
Sabra Healthcare REIT
SBRA
$5.34B
$78.3K ﹤0.01%
4,481
+224
+5% +$3.78K
SRRK icon
383
Scholar Rock
SRRK
$5.67B
$77K ﹤0.01%
2,396
+430
+22% +$16.5K
EPR icon
384
EPR Properties
EPR
$4.75B
$75.4K ﹤0.01%
1,434
+58
+4% +$2.85K
CRSP icon
385
CRISPR Therapeutics
CRSP
$4.73B
$74.4K ﹤0.01%
2,186
+394
+22% +$16.7K
PTGX icon
386
Protagonist Therapeutics
PTGX
$8.79B
$73.8K ﹤0.01%
1,526
+275
+22% +$11.5K
MRUS
387
DELISTED
Merus
MRUS
$73.8K ﹤0.01%
1,753
+315
+22% +$13.7K
AKRO
388
DELISTED
Akero Therapeutics
AKRO
$72.3K ﹤0.01%
1,787
+321
+22% +$13.6K
LEGN icon
389
Legend Biotech
LEGN
$3.59B
$71K ﹤0.01%
2,092
+377
+22% +$13.5K
SKT icon
390
Tanger
SKT
$4.67B
$70.9K ﹤0.01%
2,097
+110
+6% +$3.69K
ACAD icon
391
Acadia Pharmaceuticals
ACAD
$4.43B
$70.8K ﹤0.01%
4,260
+766
+22% +$13.9K
SG icon
392
Sweetgreen
SG
$766M
$70.7K ﹤0.01%
+2,824
New +$77.9K
APLS
393
DELISTED
Apellis Pharmaceuticals
APLS
$69.7K ﹤0.01%
3,185
+573
+22% +$15.8K
KRC icon
394
Kilroy Realty
KRC
$4.52B
$69.6K ﹤0.01%
2,124
+98
+5% +$3.51K
AMRX icon
395
Amneal Pharmaceuticals
AMRX
$5.85B
$66.5K ﹤0.01%
7,934
+1,428
+22% +$11.9K
ALVO icon
396
Alvotech
ALVO
$1.39B
$66.1K ﹤0.01%
6,832
+1,229
+22% +$14.9K
XENE icon
397
Xenon Pharmaceuticals
XENE
$6.06B
$65.5K ﹤0.01%
1,952
+351
+22% +$13.3K
IMVT icon
398
Immunovant
IMVT
$7.94B
$64.2K ﹤0.01%
3,758
+676
+22% +$14.1K
NHI icon
399
National Health Investors
NHI
$3.72B
$63.5K ﹤0.01%
860
+20
+2% +$1.41K
FOLD
400
DELISTED
Amicus Therapeutics
FOLD
$62.4K ﹤0.01%
7,651
+1,377
+22% +$12.7K
14 15
16
17 18

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, GF Fund Management held 683 positions worth $4.26B, down 7.8% from $4.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q1 2025 filing shows 46 new, 475 increased, 93 reduced and 17 closed positions. Its largest new stake was Hims & Hers Health: 368,661 shares worth $10.9M. The largest sale was Pinduoduo, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q1 2025 buy was Hims & Hers Health: 368,661 shares worth $10.9M.
  • GF Fund Management added most to Philip Morris in Q1 2025, an estimated $38.3M increase.
  • GF Fund Management's biggest Q1 2025 reduction was Pinduoduo, cutting an estimated $39.4M.
  • GF Fund Management fully exited Applied Optoelectronics in Q1 2025, selling an estimated $5.07M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.26B portfolio in Q1 2025.
  • GF Fund Management opened 46 new positions and closed 17 in Q1 2025.
  • GF Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.26B.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.